David Lelan Brand, PA
Physician Assistant · Walnut Creek
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Offices
- 4
- Since medical school
- 20 years
- Graduated 2006
Offices
4 locations · Golden State Orthopedics and Spine · 186 clinicians in this group
Looking this up.
Hospitals listed: John Muir Medical Center - Concord Campus · John Muir Medical Center - Walnut Creek Campus. That is not proof they admit you there this week.
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call David Lelan Brand’s office at (925) 939-8585 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- John Muir Medical Center - Concord CampusConcord, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.235, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.675, Oct 2024 – Sep 2025
- John Muir Medical Center - Walnut Creek CampusWalnut Creek, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of John Muir Health, which runs 3 hospitalsPatients rate it 3 of 5 · 77% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — Abdominopelvic accidental puncture or laceration rate: 2.01 (1.17 to 2.85) · 2,206 cases, Jul 2022 – Jun 2024Worse than the national rate — Death rate among surgical inpatients with serious treatable complications: 222.42 (177.82 to 267.02) · 120 cases, Jul 2022 – Jun 2024Worse than the national rate — Pressure ulcer rate: 1.4 (0.91 to 1.9) · 9,764 cases, Jul 2022 – Jun 2024Worse than the national rate — SSI - Colon Surgery: 2.734, Oct 2024 – Sep 2025Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.536, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.341, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.455, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.245, Oct 2024 – Sep 2025
See every measure and the patient survey for John Muir Medical Center - Concord Campus
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 0 better, 7 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.235 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.675 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.11 (0.21 to 2) · 1,612 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.77 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 184.13 (136.65 to 231.6) · 86 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.2 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.4 · 172 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8 · 537 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.5 · 434 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13 · 215 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,208 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.32 (0.13 to 0.51) · 7,626 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 8,660 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.1 (1.29 to 4.91) · 2,723 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.21 (0 to 2.51) · 1,208 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3 (1.7 to 4.3) · 2,355 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.77 (3.24 to 12.3) · 1,216 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.43 (0.43 to 6.43) · 1,253 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.93 (0.47 to 3.4) · 388 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.14 (0.58 to 1.69) · 6,288 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.1 · 263 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.636 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.254 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.904 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.5 · 312 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.1 · 768 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -6.8 · 295 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -3.1 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 31.1 · 433 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 504 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.7 (5.1 to 8.8) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.9 (10.5 to 15.7) · 476 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 8.8 · 154 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.7 · 186 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.4 (9.9 to 17.9) · 192 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.2) · 546 cases | No different | Jan 2024 – Dec 2024 |
What patients said (521 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 72% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
See every measure and the patient survey for John Muir Medical Center - Walnut Creek Campus
Behind the star rating — Deaths: 3 better, 2 the same, 2 worse of 7 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 3 better, 5 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 2.01 (1.17 to 2.85) · 2,206 cases | Worse | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 222.42 (177.82 to 267.02) · 120 cases | Worse | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.4 (0.91 to 1.9) · 9,764 cases | Worse | Jul 2022 – Jun 2024 |
| SSI - Colon SurgeryInfections | 2.734 | Worse | Oct 2024 – Sep 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.536 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.341 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.455 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.245 | Better | Oct 2024 – Sep 2025 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.14 (0.87 to 1.4) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 131 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 148 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 695 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 12.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.1 · 509 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 4,483 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.35 (0.18 to 0.53) · 11,630 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.05 to 0.39) · 11,793 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.33 (1.69 to 4.96) · 3,268 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.37 (0 to 2.94) · 1,631 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.76 (1.43 to 4.09) · 3,066 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.12 (0.22 to 12.02) · 1,580 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.43 (1.21 to 7.64) · 1,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 685 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 615 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 1.88 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 93 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 729 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -30.1 · 91 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13 · 736 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.8 · 842 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.7 · 818 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.3 (3.3 to 8.4) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (7.2 to 15.5) · 28 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 4.9 · 584 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.9) · 222 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.5) · 321 cases | No different | Jan 2024 – Dec 2024 |
What patients said (758 patients answered, 24% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 55% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 69% |
| Staff "always" explained new medications | 68% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 77% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$151,647
Medicare paid this office $151,647 for 560 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 264 | $22,548 | $66 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 30 | $21,207 | None |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 40 | $19,269 | None |
| Return visit (30+ min) | 184 | $18,175 | $92 |
| Aspiration and/or injection of fluid from large joint | 179 | $15,661 | $56 |
See all 17 services
| Short return visit (20+ min) | 264 | $22,548 | $66 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 30 | $21,207 | None |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 40 | $19,269 | None |
| Return visit (30+ min) | 184 | $18,175 | $92 |
| Aspiration and/or injection of fluid from large joint | 179 | $15,661 | $56 |
| X-ray of knee, 3 views | 197 | $10,013 | $34 |
| Replacement of knee joint, both sides of knee | 61 | $8,743 | $141 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 47 | $5,458 | $87 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 20 | $4,687 | $213 |
| Replacement of thigh bone and hip joint with prosthesis | 30 | $4,675 | $156 |
| X-ray of hip, 2-3 views | 72 | $3,320 | $40 |
| New patient visit (30+ min) | 22 | $1,661 | $75 |
| X-ray of knee, 4 or more views | 26 | $1,585 | $42 |
| New patient visit (45+ min) | 11 | $1,467 | $133 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 151 | $887 | None |
| X-ray of both hips, 3-4 views | 19 | $839 | $42 |
| X-ray of hip, minimum of 4 views | 12 | $495 | $41 |
Procedures Medicare counted
| Hip replacement | 34 | More than 79% of doctors who do this |
| Knee replacement | 84 | More than 90% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 521 | 449 | 384 | 384 | 362 | 278 |
| Replacement of knee joint, both sides of knee | 76 | 59 | 68 | 54 | 72 | 62 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 77 | 47 | 68 | 60 | 57 | 63 |
| Replacement of thigh bone and hip joint with prosthesis | 28 | 13 | 23 | 28 | 27 | 30 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 17 | 18 | 19 | 23 | 26 | 22 |
| Revision of thigh bone and hip joint prosthesis | – | 14 | 16 | 14 | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
560 Original Medicare patients in 2024. Average age 76 · Under 65 6% · 85 and older 15% · Women 63% · Also on Medicaid 32% · Health risk score 1.35. Above the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Diabetes 31% · Depression 28% · Coronary heart disease 25% · Chronic kidney disease 25% · Atrial fibrillation 23% · Heart failure 17% · Cancer 14% · COPD 14% · Dementia 7% · Stroke 7%.
The office billed $735,349, Medicare allowed $202,461 and paid $151,647; for 12,016 services of 49 kinds; $43,765 of it was for drugs given in the office and $107,882 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 560 | 12,016 | 76 | 1.35 | $735,349 | $151,647 |
| 2023 | 581 | 26,888 | 75 | 1.29 | $814,990 | $172,655 |
| 2022 | 507 | 20,070 | 75 | 1.18 | $702,520 | $214,376 |
| 2021 | 418 | 44,737 | 74 | 1.18 | $460,842 | $199,145 |
| 2020 | 380 | 57,431 | 74 | 1.27 | $442,142 | $194,454 |
| 2019 | 520 | 47,119 | 74 | 1.32 | $531,939 | $224,157 |
| 2018 | 592 | 39,659 | 74 | 1.36 | $534,729 | $198,748 |
| 2017 | 579 | 22,191 | 74 | 1.36 | $535,776 | $181,775 |
| 2016 | 471 | 2,956 | 73 | 1.28 | $325,376 | $100,287 |
| 2015 | 356 | 2,062 | 72 | 1.26 | $185,371 | $59,990 |
| 2014 | 350 | 1,905 | 73 | 1.23 | $183,829 | $58,766 |
| 2013 | 321 | 1,517 | 73 | 1.22 | $161,803 | $53,555 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 20 services
| Return visit (30+ min) | 249 | $26,438 | $94 |
| Aspiration and/or injection of fluid from large joint | 206 | $20,792 | $57 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 44 | $19,844 | None |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 38 | $19,546 | None |
| Short return visit (20+ min) | 204 | $15,606 | $65 |
| X-ray of knee, 3 views | 210 | $11,366 | $34 |
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 21 | $10,909 | None |
| Replacement of knee joint, both sides of knee | 71 | $10,446 | $145 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 26 | $5,354 | $206 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 45 | $4,745 | $83 |
| Replacement of thigh bone and hip joint with prosthesis | 26 | $4,076 | $151 |
| New patient visit (30+ min) | 39 | $3,155 | $81 |
| X-ray of hip, 2-3 views | 60 | $2,362 | $37 |
| X-ray of hip, minimum of 4 views | 38 | $2,088 | $50 |
| X-ray of knee, 4 or more views | 40 | $1,896 | $36 |
| New patient visit (45+ min) | 14 | $1,696 | $121 |
| X-ray of both hips, 3-4 views | 19 | $905 | $45 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 159 | $905 | None |
| X-ray of lower and sacral spine, 2-3 views | 20 | $672 | $34 |
| X-ray of thigh bone, minimum 2 views | 14 | $456 | $25 |
2022: 22 services
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 43 | $46,294 | None |
| Return visit (30+ min) | 255 | $27,923 | $96 |
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 20 | $25,853 | None |
| Aspiration and/or injection of fluid from large joint | 188 | $23,171 | $60 |
| Hyaluronan or derivative, trivisc, for intra-articular injection, 1 mg | 18 | $17,530 | None |
| Short return visit (20+ min) | 179 | $14,404 | $68 |
| X-ray of knee, 3 views | 162 | $8,529 | $35 |
| Replacement of knee joint, both sides of knee | 50 | $8,455 | $157 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 21 | $4,888 | $213 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 51 | $4,847 | $81 |
| Replacement of thigh bone and hip joint with prosthesis | 27 | $4,376 | $156 |
| Revision of thigh bone and hip joint prosthesis | 12 | $3,223 | $230 |
| New patient visit (45+ min) | 24 | $3,155 | $131 |
| X-ray of hip, 2-3 views | 54 | $2,396 | $40 |
| X-ray of hip, minimum of 4 views | 37 | $2,209 | $50 |
| X-ray of knee, 4 or more views | 27 | $1,409 | $39 |
| New patient visit (30+ min) | 12 | $1,065 | $89 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 160 | $987 | None |
| X-ray of both hips, 3-4 views | 13 | $662 | $47 |
| X-ray of lower and sacral spine, 2-3 views | 17 | $526 | $31 |
| X-ray of both hips, 2 views | 12 | $408 | $34 |
| X-ray of thigh bone, minimum 2 views | 12 | $378 | $29 |
2021: 21 services
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 49 | $71,735 | None |
| Aspiration and/or injection of fluid from large joint | 163 | $21,964 | $57 |
| Return visit (30+ min) | 145 | $17,202 | $102 |
| Hyaluronan or derivative, durolane, for intra-articular injection, 1 mg | 13 | $13,122 | None |
| Replacement of knee joint, both sides of knee | 63 | $10,621 | $156 |
| Short return visit (20+ min) | 144 | $10,303 | $58 |
| X-ray of knee, 3 views | 120 | $6,118 | $34 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 54 | $6,025 | $89 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 15 | $4,734 | None |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 18 | $4,122 | $217 |
| Revision of thigh bone and hip joint prosthesis | 14 | $3,751 | $234 |
| Replacement of thigh bone and hip joint with prosthesis | 23 | $3,657 | $159 |
| New patient visit (45+ min) | 17 | $2,265 | $133 |
| X-ray of hip, 2-3 views | 48 | $2,058 | $40 |
| New patient visit (30+ min) | 19 | $1,402 | $74 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 133 | $951 | None |
| X-ray of knee, 4 or more views | 16 | $876 | $35 |
| X-ray of both hips, 3-4 views | 15 | $753 | $47 |
| X-ray of knee, 1-2 views | 20 | $724 | $29 |
| X-ray of hip, minimum of 4 views | 12 | $592 | $46 |
| X-ray of pelvis, minimum of 3 views | 12 | $402 | $34 |
2020: 16 services
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 79 | $99,350 | None |
| Aspiration and/or injection of fluid from large joint | 166 | $23,904 | $53 |
| Short return visit (20+ min) | 208 | $14,734 | $54 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 14 | $9,765 | None |
| Replacement of knee joint, both sides of knee | 57 | $8,676 | $147 |
| X-ray of knee, 3 views | 122 | $5,775 | $33 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 16 | $3,970 | $221 |
| New patient visit (30+ min) | 49 | $3,784 | $77 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 39 | $3,607 | $77 |
| Revision of thigh bone and hip joint prosthesis | 11 | $3,335 | $238 |
| Replacement of thigh bone and hip joint with prosthesis | 13 | $1,919 | $148 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 123 | $1,049 | None |
| X-ray of hip, minimum of 4 views | 18 | $936 | $49 |
| X-ray of pelvis, minimum of 3 views | 24 | $846 | $33 |
| X-ray of hip, 2-3 views | 16 | $573 | $36 |
| X-ray of lower and sacral spine, 2-3 views | 17 | $566 | $33 |
2019: 17 services
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 59 | $79,425 | None |
| Aspiration and/or injection of fluid from large joint | 201 | $27,918 | $54 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 35 | $24,522 | None |
| Short return visit (20+ min) | 303 | $21,918 | $54 |
| Replacement of knee joint, both sides of knee | 68 | $12,300 | $162 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 18 | $10,258 | None |
| X-ray of knee, 3 views | 142 | $6,020 | $31 |
| New patient visit (30+ min) | 72 | $5,570 | $77 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 58 | $5,399 | $70 |
| Replacement of thigh bone and hip joint with prosthesis | 26 | $4,613 | $165 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 17 | $3,689 | $217 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 182 | $1,708 | None |
| X-ray of hip, 2-3 views | 40 | $1,469 | $35 |
| X-ray of pelvis, minimum of 3 views | 36 | $1,119 | $29 |
| X-ray of knee, 4 or more views | 20 | $864 | $35 |
| X-ray of lower and sacral spine, 2-3 views | 22 | $693 | $31 |
| X-ray of thigh bone, minimum 2 views | 11 | $317 | $29 |
2018: 18 services
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 49 | $65,570 | None |
| Aspiration and/or injection of fluid from large joint | 223 | $25,626 | $45 |
| Short return visit (20+ min) | 353 | $24,629 | $51 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 22 | $11,759 | None |
| Replacement of knee joint, both sides of knee | 63 | $10,119 | $151 |
| New patient visit (30+ min) | 110 | $8,020 | $73 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 17 | $7,576 | None |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 11 | $6,044 | None |
| X-ray of knee, 3 views | 147 | $5,792 | $28 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 64 | $5,214 | $68 |
| Replacement of thigh bone and hip joint with prosthesis | 28 | $4,451 | $159 |
| X-ray of hip, 2-3 views | 91 | $3,255 | $31 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 217 | $2,177 | None |
| X-ray of knee, 4 or more views | 28 | $1,105 | $29 |
| X-ray of lower and sacral spine, 2-3 views | 37 | $999 | $27 |
| X-ray of both hips, 3-4 views | 16 | $620 | $39 |
| X-ray of both hips, 2 views | 15 | $425 | $28 |
| X-ray of thigh bone, minimum 2 views | 11 | $296 | $27 |
2017: 18 services
| Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | 25 | $33,987 | None |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 72 | $33,196 | None |
| Aspiration and/or injection of fluid from large joint | 228 | $28,338 | $38 |
| Short return visit (20+ min) | 320 | $20,556 | $50 |
| Replacement of knee joint, both sides of knee | 68 | $10,277 | $151 |
| Hyaluronan or derivative, gel-one, for intra-articular injection, per dose | 14 | $9,766 | None |
| New patient visit (30+ min) | 125 | $8,623 | $69 |
| X-ray of knee, 3 views | 134 | $4,891 | $26 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 48 | $3,761 | $67 |
| Replacement of thigh bone and hip joint with prosthesis | 24 | $3,597 | $144 |
| X-ray of hip, 2-3 views | 90 | $2,910 | $31 |
| Revision of thigh and lower leg bone components of total knee joint prosthesis | 13 | $2,681 | $206 |
| X-ray of knee, 4 or more views | 51 | $2,072 | $32 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 204 | $1,960 | None |
| Treatment of upper end of broken thigh bone with placement of stabilizing device or prosthetic replacement | 12 | $1,694 | $141 |
| X-ray of lower and sacral spine, 2-3 views | 31 | $725 | $23 |
| X-ray of both hips, 2 views | 14 | $389 | $28 |
| Short return visit | 11 | $340 | $31 |
2016: 16 services
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 43 | $20,218 | None |
| Short return visit (20+ min) | 233 | $14,122 | $51 |
| Aspiration and/or injection of fluid from large joint | 119 | $12,464 | $37 |
| New patient visit (30+ min) | 74 | $5,613 | $76 |
| Return visit (30+ min) | 63 | $4,863 | $76 |
| Replacement of knee joint, both sides of knee | 25 | $3,961 | $158 |
| X-ray of knee, 3 views | 93 | $3,709 | $28 |
| Replacement of thigh bone and hip joint with prosthesis | 15 | $2,237 | $149 |
| X-ray of foot, minimum of 3 views | 77 | $2,160 | $21 |
| X-ray of hip, 2-3 views | 38 | $1,344 | $33 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 115 | $1,080 | None |
| Aspiration and/or injection of fluid from medium joint | 17 | $966 | $37 |
| Aspiration and/or injection of fluid large joint using ultrasound guidance | 13 | $924 | $66 |
| X-ray of ankle, minimum of 3 views | 33 | $869 | $23 |
| Short return visit | 14 | $570 | $32 |
| X-ray of lower and sacral spine, 2-3 views | 11 | $302 | $27 |
2015: 13 services
| Short return visit (20+ min) | 190 | $14,894 | $51 |
| Return visit (30+ min) | 69 | $5,420 | $79 |
| New patient visit (30+ min) | 72 | $5,311 | $74 |
| X-ray of foot, minimum of 3 views | 129 | $4,055 | $21 |
| Aspiration and/or injection of fluid from medium joint | 47 | $2,481 | $38 |
| Closed treatment of broken bone in forefoot or midfoot | 13 | $2,444 | $153 |
| X-ray of ankle, minimum of 3 views | 65 | $2,293 | $24 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 15 | $2,179 | $32 |
| Aspiration and/or injection of fluid from large joint | 25 | $2,022 | $40 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 69 | $835 | None |
| Removal of deep implant from bone | 13 | $627 | $48 |
| X-ray of foot, 2 views | 18 | $354 | $19 |
| X-ray of ankle, 2 views | 12 | $235 | $17 |
2014: 13 services
| Short return visit (20+ min) | 196 | $14,675 | $51 |
| Return visit (30+ min) | 57 | $4,433 | $78 |
| New patient visit (30+ min) | 61 | $4,065 | $67 |
| X-ray of foot, minimum of 3 views | 111 | $3,935 | $23 |
| Closed treatment of broken outside lower leg bone at ankle | 11 | $2,610 | $237 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 17 | $2,250 | $31 |
| Aspiration and/or injection of fluid from medium joint | 42 | $2,214 | $38 |
| Aspiration and/or injection of fluid from large joint | 28 | $1,939 | $40 |
| X-ray of ankle, minimum of 3 views | 47 | $1,727 | $25 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 63 | $694 | None |
| X-ray of knee, 4 or more views | 13 | $556 | $35 |
| X-ray of foot, 2 views | 18 | $437 | $21 |
| X-ray of ankle, 2 views | 12 | $414 | $23 |
2013: 12 services
| Short return visit (20+ min) | 182 | $12,571 | $52 |
| New patient visit (30+ min) | 74 | $5,185 | $70 |
| X-ray of foot, minimum of 3 views | 110 | $4,199 | $25 |
| Return visit (30+ min) | 40 | $2,753 | $69 |
| X-ray of ankle, minimum of 3 views | 62 | $2,253 | $26 |
| Cast supplies, short leg cast, adult (11 years +), fiberglass | 19 | $2,248 | $31 |
| Closed treatment of broken bone in forefoot or midfoot | 11 | $2,217 | $158 |
| Aspiration and/or injection of fluid from medium joint | 33 | $2,180 | $45 |
| Aspiration and/or injection of fluid from large joint | 21 | $1,752 | $42 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 60 | $645 | None |
| Short return visit | 11 | $582 | $34 |
| X-ray of foot, 2 views | 11 | $245 | $22 |
Medicaid work
$13,037 in 2024
Medicaid paid $13,037 for 189 billed services this clinician did in 2024, up to 18 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Short return visit (20+ min) | 57 | $5,811 |
| Radiologic examination, knee; 3 views | 74 | $3,258 |
| Arthrocentesis and injection of knee joint | 31 | $2,014 |
| Return visit (30+ min) | 13 | $1,879 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 14 | $75 |
| 2024 | 189 | 5 | 18 | $13,037 |
| 2023 | 246 | 4 | 18 | $15,222 |
| 2022 | 43 | 2 | 15 | $3,591 |
| 2021 | 57 | 2 | 16 | $3,137 |
| 2020 | 33 | 1 | 14 | $1,729 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 64 | $7,151 |
| Radiologic examination, knee; 3 views | 104 | $3,439 |
| Arthrocentesis and injection of knee joint | 53 | $2,576 |
| Short return visit (20+ min) | 25 | $2,057 |
2022
| Return visit (30+ min) | 29 | $3,095 |
| Radiologic examination, knee; 3 views | 14 | $496 |
2021
| Arthrocentesis and injection of knee joint | 43 | $2,104 |
| Return visit (30+ min) | 14 | $1,033 |
2020
| Arthrocentesis and injection of knee joint | 33 | $1,729 |
Drugs they prescribed that Part D paid
$4,261
Pharmacies billed $4,261 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 41% of their Part D prescriptions (79 of 192) in 2024. A higher opioid share than 9 in 10 peers; the typical physician assistant clinician is at 1%.
181 generic and 11 brand-name prescriptions · $4,261 in drug cost · 35 antibiotic prescriptions to 27 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 38 | $1,826 | $48 |
| Cephalexin | 15 | $259 | $17 |
| Hydromorphone | 35 | $231 | $7 |
| Ibuprofen | 15 | $152 | $10 |
| Hydrocodone-Acetaminophen | 12 | $139 | $12 |
See all 8 drugs
| Celecoxib | 38 | $1,826 | $48 |
| Cephalexin | 15 | $259 | $17 |
| Hydromorphone | 35 | $231 | $7 |
| Ibuprofen | 15 | $152 | $10 |
| Hydrocodone-Acetaminophen | 12 | $139 | $12 |
| Oxycodone | 12 | $111 | $9 |
| Tramadol | 19 | $54 | $3 |
| Amoxicillin | 14 | $38 | $3 |
Year by year
| 2024 | 192 | 108 | 41% (79) | 6% | $4,261 |
| 2023 | 213 | 99 | 39% (82) | 5% | $4,191 |
| 2022 | 210 | 90 | 28% (59) | 9% | $6,489 |
| 2021 | 210 | 105 | 27% (56) | 10% | $7,873 |
| 2020 | 286 | 103 | 17% (48) | 8% | $15,865 |
| 2019 | 257 | 117 | 27% (68) | 7% | $20,700 |
| 2018 | 286 | 140 | 35% (101) | 13% | $108,467 |
| 2017 | 363 | 153 | 31% (112) | 21% | $187,321 |
| 2016 | 225 | 137 | 56% (127) | 5% | $43,637 |
| 2015 | 133 | 84 | 65% (87) | None | $8,125 |
| 2014 | 112 | 83 | 65% (73) | 10% | $4,675 |
| 2013 | 101 | 70 | 56% (57) | 18% | $4,124 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Celecoxib | 27 | $1,005 | $37 |
| Hydromorphone | 52 | $484 | $9 |
| Cephalexin | 18 | $463 | $26 |
| Ibuprofen | 11 | $179 | $16 |
| Tramadol | 16 | $120 | $8 |
| Gabapentin | 11 | $119 | $11 |
| Amoxicillin | 15 | $35 | $2 |
2022: 9 drugs
| Celecoxib | 40 | $1,806 | $45 |
| Diclofenac | 13 | $415 | $32 |
| Oxycodone | 27 | $285 | $11 |
| Cyclobenzaprine | 13 | $166 | $13 |
| Cephalexin | 13 | $140 | $11 |
| Ibuprofen | 12 | $109 | $9 |
| Gabapentin | 18 | $103 | $6 |
| Hydromorphone | 12 | $68 | $6 |
| Tramadol | 15 | $57 | $4 |
2021: 8 drugs
| Eliquis | 12 | $3,010 | $251 |
| Celecoxib | 25 | $1,243 | $50 |
| Oxycodone | 29 | $278 | $10 |
| Cephalexin | 22 | $160 | $7 |
| Cyclobenzaprine | 12 | $134 | $11 |
| Hydromorphone | 12 | $96 | $8 |
| Gabapentin | 12 | $45 | $4 |
| Amoxicillin | 11 | $33 | $3 |
2020: 8 drugs
| Fluocinonide | 22 | $3,477 | $158 |
| Diclofenac | 61 | $3,369 | $55 |
| Lidocaine | 17 | $3,021 | $178 |
| Lidocaine-Prilocaine | 32 | $2,056 | $64 |
| Hydromorphone | 35 | $334 | $10 |
| Ibuprofen | 17 | $238 | $14 |
| Naproxen | 12 | $139 | $12 |
| Cyclobenzaprine | 15 | $103 | $7 |
2019: 8 drugs
| Diclofenac | 43 | $2,772 | $64 |
| Lidocaine-Prilocaine | 30 | $2,470 | $82 |
| Oxycodone-Acetaminophen | 20 | $354 | $18 |
| Hydrocodone-Acetaminophen | 22 | $249 | $11 |
| Ibuprofen | 21 | $246 | $12 |
| Oxycodone | 11 | $161 | $15 |
| Naproxen | 12 | $91 | $8 |
| Ibu | 12 | $74 | $6 |
2018: 9 drugs
| Doxepin | 23 | $49,720 | $2,162 |
| Diclofenac | 26 | $13,388 | $515 |
| Lidocaine | 24 | $12,865 | $536 |
| Lidocaine-Prilocaine | 22 | $3,060 | $139 |
| Voltaren | 14 | $1,574 | $112 |
| Oxycodone-Acetaminophen | 48 | $974 | $20 |
| Hydrocodone-Acetaminophen | 34 | $498 | $15 |
| Ibuprofen | 20 | $211 | $11 |
| Ibu | 13 | $87 | $7 |
2017: 10 drugs
| Doxepin | 51 | $117,300 | $2,300 |
| Diclofenac | 46 | $27,826 | $605 |
| Fluocinonide | 12 | $20,651 | $1,721 |
| Lidocaine | 17 | $9,554 | $562 |
| Lidocaine-Prilocaine | 56 | $8,796 | $157 |
| Oxycodone-Acetaminophen | 35 | $871 | $25 |
| Hydrocodone-Acetaminophen | 46 | $455 | $10 |
| Ibuprofen | 22 | $156 | $7 |
| Cephalexin | 12 | $138 | $12 |
| Tramadol | 17 | $78 | $5 |
2016: 7 drugs
| Lidocaine | 23 | $23,749 | $1,033 |
| Lidocaine-Prilocaine | 20 | $8,501 | $425 |
| Diclofenac | 14 | $6,256 | $447 |
| Hydrocodone-Acetaminophen | 67 | $1,236 | $18 |
| Oxycodone-Acetaminophen | 38 | $1,211 | $32 |
| Tramadol | 17 | $145 | $9 |
| Ibuprofen | 17 | $143 | $8 |
2015: 3 drugs
| Oxycodone-Acetaminophen | 42 | $827 | $20 |
| Hydrocodone-Acetaminophen | 36 | $629 | $17 |
| Cephalexin | 12 | $82 | $7 |
2014: 3 drugs
| Hydrocodone-Acetaminophen | 40 | $585 | $15 |
| Oxycodone-Acetaminophen | 21 | $429 | $20 |
| Cephalexin | 13 | $85 | $7 |
2013: 2 drugs
| Hydrocodone-Acetaminophen | 32 | $488 | $15 |
| Oxycodone-Acetaminophen | 12 | $112 | $9 |
Money from drug and device companies
$21 in 2024
| 2024 | 1 | 1 | None | $21 |
| 2023 | 2 | 3 | None | $182 |
| 2022 | 4 | 6 | None | $200 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Si-Bone | None | $21 | 1 payment
|
See the published payment
| Si-Bone | Meals · 2024-01-24 | None | $21 |
See earlier years (2023, 2022)
2023: $182
| Zimmer Biomet Holdings | None | $128 | 1 payment
|
| Bioventus | Exogen Ultrasound Bone Healing System | $55 | 2 payments
|
2022: $200
| Zimmer Biomet Holdings | Rosa | $117 | 2 payments
|
| Si-Bone | None | $42 | 2 payments
|
| Medical Device Business Services | None | $24 | 1 payment
|
| Bioventus | Durolane | $17 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 75.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1346366556
- Licence
- CA PA19049
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant, surgical (363AS0400X); Physician assistant, medical (363AM0700X)
- Mailing address
- Po Box 31396, Walnut Creek, CA, 94598
- NPI first listed
- 2007-03-21
- NPI last updated
- 2020-09-18
- NPI record certified
- 2020-09-18
This is when the NPI record was last certified, not a medical board exam.